ImmunityBio Inc. (NASDAQ:IBRX) is one of the 10 Must-Watch Stocks Right Now. ImmunityBio surged by 7.29 percent on Friday to ...
The first and largest dataset of genomic structure variations specific to childhood cancers was published today by scientists ...
ImmunityBio (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced the successful completion of manufacturing engineering programs, NK2022 and NK2023, establishing a safe, ...
A group of natural compounds attracting attention for their anti-aging potential has a dark side. New research shows how a ...
Scientists have developed an AI system that analyzes complex gene-expression signatures to estimate the likelihood that a tumor will spread.
A chronological map of the fetal brain reveals when key cells emerge and provides clues about autism and cancer.
Spermidine, a polyamine, has been linked to longer lifespans, improved health, and lessening memory loss with age, and it’s ...
Medicus Pharma (NASDAQ:MDCX) said on Monday that new analysis of data from a mid-stage clinical trial of its SkinJect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results